These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16227233)

  • 41. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120.
    Yolitz J; Schwing C; Chang J; Van Ryk D; Nawaz F; Wei D; Cicala C; Arthos J; Fauci AS
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2443-2448. PubMed ID: 29463753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor.
    Jagodzinski PP; Wierzbicki A; Wustner J; Kaneko Y; Kozbor D
    Viral Immunol; 1999; 12(1):23-33. PubMed ID: 10333239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.
    Hemming A; Gram GJ; Bolmstedt A; Losman B; Hansen JE; Ricksten A; Olofsson S
    Arch Virol; 1996; 141(11):2139-51. PubMed ID: 8973529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased antiviral and opsonic activity of a highly multimerized collectin chimera.
    White MR; Crouch E; Chang D; Hartshorn KL
    Biochem Biophys Res Commun; 2001 Aug; 286(1):206-13. PubMed ID: 11485330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization.
    Ying H; Ji X; Hart ML; Gupta K; Saifuddin M; Zariffard MR; Spear GT
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):327-35. PubMed ID: 15117456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity.
    Dirckx L; Lindemann D; Ette R; Manzoni C; Moritz D; Mous J
    Virus Res; 1990 Dec; 18(1):9-20. PubMed ID: 2082620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    Zhou R; Wang X; Liu H; Guo L; Su Q; Wang H; Vasiliadis T; Ho W; Li J
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.
    Hsieh IN; De Luna X; White MR; Hartshorn KL
    Front Immunol; 2018; 9():1368. PubMed ID: 29951070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
    McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
    Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
    Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
    AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Species differences in the carbohydrate binding preferences of surfactant protein D.
    Crouch EC; Smith K; McDonald B; Briner D; Linders B; McDonald J; Holmskov U; Head J; Hartshorn K
    Am J Respir Cell Mol Biol; 2006 Jul; 35(1):84-94. PubMed ID: 16514117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collectins and host defence.
    Sim RB; Clark H; Hajela K; Mayilyan KR
    Novartis Found Symp; 2006; 279():170-81; discussion 181-6, 216-9. PubMed ID: 17278394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
    Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
    J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.